<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">72943</article-id><article-id pub-id-type="doi">10.7554/eLife.72943</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group></article-categories><title-group><article-title>Lipid droplets and ferritin heavy chain: a devilish liaison in human cancer cell radioresistance</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-249216"><name><surname>Tirinato</surname><given-names>Luca</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9826-2129</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-249217"><name><surname>Marafioti</surname><given-names>Maria Grazia</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-249218"><name><surname>Pagliari</surname><given-names>Francesca</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-249219"><name><surname>Jansen</surname><given-names>Jeannette</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8625-3978</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-249220"><name><surname>Aversa</surname><given-names>Ilenia</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-249221"><name><surname>Hanley</surname><given-names>Rachel</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2627-1146</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-249222"><name><surname>Nisticò</surname><given-names>Clelia</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0787-9527</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-249223"><name><surname>Garcia-Calderón</surname><given-names>Daniel</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-249224"><name><surname>Genard</surname><given-names>Geraldine</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9495-0335</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-249225"><name><surname>Guerreiro</surname><given-names>Joana Filipa</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1960-603X</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-249226"><name><surname>Costanzo</surname><given-names>Francesco Saverio</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-249227"><name><surname>Seco</surname><given-names>Joao</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9458-2202</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="corresp" rid="cor3">*</xref><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution>Magna Graecia University</institution>, <addr-line><named-content content-type="city">Catanzaro</named-content></addr-line>, <country>Italy</country></aff><aff id="aff2"><institution>German Cancer Research Center</institution>, <addr-line><named-content content-type="city">Heidelberg</named-content></addr-line>, <country>Germany</country></aff><aff id="aff3"><institution>University of Lisbon</institution>, <addr-line><named-content content-type="city">Lisboa</named-content></addr-line>, <country>Portugal</country></aff><aff id="aff4"><institution>DKFZ - German Cancer Research Center</institution>, <addr-line><named-content content-type="city">Heidelberg</named-content></addr-line>, <country>Germany</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-238838"><name><surname>El-Deiry</surname><given-names>Wafik S</given-names></name><role>Reviewing editor</role><aff><institution>Brown University</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>tirinato@unicz.it</email> (LT);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>f.pagliari@dkfz.de</email> (FP);</corresp><corresp id="cor3"><label>*</label>For correspondence: <email>j.seco@dkfz.de</email> (JS);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>09</day><month>09</month><year>2021</year></pub-date><volume>10</volume><elocation-id>e72943</elocation-id><history><date date-type="received"><day>12</day><month>08</month><year>2021</year></date><date date-type="accepted"><day>25</day><month>08</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Tirinato et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Tirinato et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-72943-v1.pdf"/><abstract><p>Although much progress has been made in cancer treatment, the molecular mechanisms underlying cancer radioresistance (RR) as well as the biological signatures of radioresistant cancer cells still need to be clarified. In this regard, we discovered that breast, bladder, lung, neuroglioma and prostate 6 Gy X-ray resistant cancer cells were characterized by an increase of Lipid Droplet (LD) number and that the cells containing highest LDs showed the highest clonogenic potential after irradiation. Moreover, we observed that LD content was tightly connected with the iron metabolism and in particular with the presence of the ferritin heavy chain (FTH1). In fact, breast and lung cancer cells silenced for the FTH1 gene showed a reduction in the LD numbers and, by consequence, became radiosensitive. FTH1 overexpression as well as iron-chelating treatment by Deferoxamine were able to restore the LD amount and RR. Overall, these results provide evidence of a novel mechanism behind RR in which LDs and FTH1 are tightly connected to each other, a synergistic effect which might be worth deeply investigating in order to make cancer cells more radiosensitive and improve the efficacy of radiation treatments.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution>AIRC</institution></institution-wrap></funding-source><award-id>800924</award-id><principal-award-recipient><name><surname>Tirinato</surname><given-names>Luca</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analyzed during this study are included in the manuscript and supporting files. All Source data files have been provided.</p></sec><supplementary-material><ext-link xlink:href="elife-72943-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>